pubmed-article:19682524 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:19682524 | lifeskim:mentions | umls-concept:C0597357 | lld:lifeskim |
pubmed-article:19682524 | lifeskim:mentions | umls-concept:C0070651 | lld:lifeskim |
pubmed-article:19682524 | lifeskim:mentions | umls-concept:C1417780 | lld:lifeskim |
pubmed-article:19682524 | lifeskim:mentions | umls-concept:C0679622 | lld:lifeskim |
pubmed-article:19682524 | lifeskim:mentions | umls-concept:C1880022 | lld:lifeskim |
pubmed-article:19682524 | lifeskim:mentions | umls-concept:C0205314 | lld:lifeskim |
pubmed-article:19682524 | lifeskim:mentions | umls-concept:C0599278 | lld:lifeskim |
pubmed-article:19682524 | pubmed:issue | 8 | lld:pubmed |
pubmed-article:19682524 | pubmed:dateCreated | 2009-10-20 | lld:pubmed |
pubmed-article:19682524 | pubmed:abstractText | The binding characteristics of [(3)H]-NPVF and [(3)H]-EYF, the two first tritiated probes for the respective labelling of NPFF(1) and NPFF(2) receptors, are presented. In membranes from CHO cells transfected with the human NPFF(1) receptor, [(3)H]-NPVF labelled one class of binding sites with a high affinity (Bmax=4pmol/mg protein, Kd=2.65nM). In membranes from CHO cells transfected with the human NPFF(2) receptor, [(3)H]-EYF labelled one class of binding sites with a high affinity (Bmax=16pmol/mg protein, Kd=0.54nM). Both radioligands exhibited time-dependent binding, low (10-20%) non-specific binding and poor cross-reactivity towards the related receptor subtype. The potency of different NPFF ligands to displace [(3)H]-NPVF and [(3)H]-EYF binding profiles was in good agreement with the profile previously measured by using (125)I-probes (NPFF(1) receptor: NPVF> or =1DMe=SPA-NPFF>NPFF=SQA-NPFF=QFW-NPSF>NPSF>RF9; NPFF(2) receptor: SPA-NPFF>>SQA-NPFF=QFW-NPSF=1DMe=NPFF>>NPSF=NPVF>RF9). Therefore, [(3)H]-NPVF and [(3)H]-EYF are new valuable tools for performing binding on NPFF receptors. | lld:pubmed |
pubmed-article:19682524 | pubmed:language | eng | lld:pubmed |
pubmed-article:19682524 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19682524 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:19682524 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19682524 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19682524 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19682524 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19682524 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19682524 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19682524 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19682524 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19682524 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19682524 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19682524 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19682524 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:19682524 | pubmed:month | Dec | lld:pubmed |
pubmed-article:19682524 | pubmed:issn | 1872-9754 | lld:pubmed |
pubmed-article:19682524 | pubmed:author | pubmed-author:MazarguilHono... | lld:pubmed |
pubmed-article:19682524 | pubmed:author | pubmed-author:TalmontFranck... | lld:pubmed |
pubmed-article:19682524 | pubmed:author | pubmed-author:ZajacJean-Mar... | lld:pubmed |
pubmed-article:19682524 | pubmed:author | pubmed-author:MollereauCath... | lld:pubmed |
pubmed-article:19682524 | pubmed:author | pubmed-author:GarciaLaura... | lld:pubmed |
pubmed-article:19682524 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:19682524 | pubmed:volume | 55 | lld:pubmed |
pubmed-article:19682524 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:19682524 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:19682524 | pubmed:pagination | 815-9 | lld:pubmed |
pubmed-article:19682524 | pubmed:meshHeading | pubmed-meshheading:19682524... | lld:pubmed |
pubmed-article:19682524 | pubmed:meshHeading | pubmed-meshheading:19682524... | lld:pubmed |
pubmed-article:19682524 | pubmed:meshHeading | pubmed-meshheading:19682524... | lld:pubmed |
pubmed-article:19682524 | pubmed:meshHeading | pubmed-meshheading:19682524... | lld:pubmed |
pubmed-article:19682524 | pubmed:meshHeading | pubmed-meshheading:19682524... | lld:pubmed |
pubmed-article:19682524 | pubmed:meshHeading | pubmed-meshheading:19682524... | lld:pubmed |
pubmed-article:19682524 | pubmed:meshHeading | pubmed-meshheading:19682524... | lld:pubmed |
pubmed-article:19682524 | pubmed:meshHeading | pubmed-meshheading:19682524... | lld:pubmed |
pubmed-article:19682524 | pubmed:meshHeading | pubmed-meshheading:19682524... | lld:pubmed |
pubmed-article:19682524 | pubmed:meshHeading | pubmed-meshheading:19682524... | lld:pubmed |
pubmed-article:19682524 | pubmed:meshHeading | pubmed-meshheading:19682524... | lld:pubmed |
pubmed-article:19682524 | pubmed:meshHeading | pubmed-meshheading:19682524... | lld:pubmed |
pubmed-article:19682524 | pubmed:meshHeading | pubmed-meshheading:19682524... | lld:pubmed |
pubmed-article:19682524 | pubmed:meshHeading | pubmed-meshheading:19682524... | lld:pubmed |
pubmed-article:19682524 | pubmed:meshHeading | pubmed-meshheading:19682524... | lld:pubmed |
pubmed-article:19682524 | pubmed:meshHeading | pubmed-meshheading:19682524... | lld:pubmed |
pubmed-article:19682524 | pubmed:meshHeading | pubmed-meshheading:19682524... | lld:pubmed |
pubmed-article:19682524 | pubmed:meshHeading | pubmed-meshheading:19682524... | lld:pubmed |
pubmed-article:19682524 | pubmed:meshHeading | pubmed-meshheading:19682524... | lld:pubmed |
pubmed-article:19682524 | pubmed:meshHeading | pubmed-meshheading:19682524... | lld:pubmed |
pubmed-article:19682524 | pubmed:meshHeading | pubmed-meshheading:19682524... | lld:pubmed |
pubmed-article:19682524 | pubmed:meshHeading | pubmed-meshheading:19682524... | lld:pubmed |
pubmed-article:19682524 | pubmed:meshHeading | pubmed-meshheading:19682524... | lld:pubmed |
pubmed-article:19682524 | pubmed:year | 2009 | lld:pubmed |
pubmed-article:19682524 | pubmed:articleTitle | Characterization of two novel tritiated radioligands for labelling Neuropeptide FF (NPFF(1) and NPFF(2)) receptors. | lld:pubmed |
pubmed-article:19682524 | pubmed:affiliation | CNRS/IPBS (Institut de Pharmacologie et Biologie Structurale), 205 route de Narbonne 31077, Toulouse cedex 5, France; Université de Toulouse, UPS, 31077 Toulouse, France. | lld:pubmed |
pubmed-article:19682524 | pubmed:publicationType | Journal Article | lld:pubmed |